FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3037821719> ?p ?o ?g. }

• W3037821719 endingPage "664" @default.
• W3037821719 startingPage "651" @default.
• W3037821719 abstract "<b><i>Introduction:</i></b> The enhanced type 2 helper (Th2) immune response is responsible for the pathogenesis of allergic asthma. To suppress the enhanced Th2 immune response, activation of the Th1 immune response has been an alternative strategy for anti-asthma therapy. In this context, effective Th1-inducing adjuvants that inhibit the development of allergic asthma but do not flare the side effects of the primary agent are required in clinical treatment and preventive medicine. <b><i>Objective:</i></b> In this study, we aimed to determine the regulation of the Th2 type immune response in asthma by a novel immunostimulatory oligodeoxynucleotide (ODN) derived from <i>Cryptococcus neoformans</i>, termed ODN112, which contains a cytosine-guanine (CG) sequence but not canonical CpG motifs. <b><i>Methods:</i></b> Using an ovalbumin-induced asthma mouse model, we assessed the effect of ODN112 on prototypical asthma-related features in the lung and on the Th1/Th2 profile in the lymph nodes and lung of mice treated with ODN112 during sensitization. <b><i>Results and Conclusion:</i></b> ODN112 treatment attenuated asthma features in mice. In the bronchial lymph nodes of the lungs and in the spleen, ODN112 increased interferon-γ production and attenuated Th2 recall responses. In dendritic cells (DCs) after allergen sensitization, ODN112 enhanced cluster of differentiation (CD) 40 and CD80 expression but did not alter CD86 expression. Interleukin-12p40 production from DCs was also increased in a Th2-polarizing condition. Our results suggest that ODN112 is a potential Th1-inducing adjuvant during Th2 cell differentiation in the sensitization phase." @default.
• W3037821719 created "2020-07-02" @default.
• W3037821719 creator A5009498218 @default.
• W3037821719 creator A5025132856 @default.
• W3037821719 creator A5027070167 @default.
• W3037821719 creator A5027365982 @default.
• W3037821719 creator A5030324982 @default.
• W3037821719 creator A5037601258 @default.
• W3037821719 creator A5039981023 @default.
• W3037821719 creator A5043422428 @default.
• W3037821719 creator A5045780806 @default.
• W3037821719 creator A5064831753 @default.
• W3037821719 creator A5065535191 @default.
• W3037821719 creator A5070984330 @default.
• W3037821719 creator A5071756329 @default.
• W3037821719 creator A5073438163 @default.
• W3037821719 creator A5083323267 @default.
• W3037821719 creator A5088330922 @default.
• W3037821719 creator A5091333394 @default.
• W3037821719 date "2020-01-01" @default.
• W3037821719 modified "2023-09-29" @default.
• W3037821719 title "Novel Toll-Like Receptor 9 Agonist Derived from <b><i>Cryptococcus neoformans</i></b> Attenuates Allergic Inflammation Leading to Asthma Onset in Mice" @default.
• W3037821719 cites W1508678300 @default.
• W3037821719 cites W1538243247 @default.
• W3037821719 cites W1655394290 @default.
• W3037821719 cites W1733554212 @default.
• W3037821719 cites W1964196894 @default.
• W3037821719 cites W1973450930 @default.
• W3037821719 cites W1975389493 @default.
• W3037821719 cites W1985422799 @default.
• W3037821719 cites W1987175539 @default.
• W3037821719 cites W1987746874 @default.
• W3037821719 cites W1992875583 @default.
• W3037821719 cites W1992985250 @default.
• W3037821719 cites W1996089447 @default.
• W3037821719 cites W1997120806 @default.
• W3037821719 cites W2008728868 @default.
• W3037821719 cites W2013394942 @default.
• W3037821719 cites W2017922016 @default.
• W3037821719 cites W2022581009 @default.
• W3037821719 cites W2034938909 @default.
• W3037821719 cites W2037061225 @default.
• W3037821719 cites W2040250565 @default.
• W3037821719 cites W2040838085 @default.
• W3037821719 cites W2045433933 @default.
• W3037821719 cites W2046107236 @default.
• W3037821719 cites W2049483717 @default.
• W3037821719 cites W2068273967 @default.
• W3037821719 cites W2075651656 @default.
• W3037821719 cites W2087234685 @default.
• W3037821719 cites W2090640877 @default.
• W3037821719 cites W2093038908 @default.
• W3037821719 cites W2093109106 @default.
• W3037821719 cites W2094807858 @default.
• W3037821719 cites W2105270641 @default.
• W3037821719 cites W2123270760 @default.
• W3037821719 cites W2127092918 @default.
• W3037821719 cites W2134204376 @default.
• W3037821719 cites W2136364590 @default.
• W3037821719 cites W2139202647 @default.
• W3037821719 cites W2159514218 @default.
• W3037821719 cites W2160655212 @default.
• W3037821719 cites W2168049552 @default.
• W3037821719 cites W2515660840 @default.
• W3037821719 cites W2755340325 @default.
• W3037821719 cites W2887461902 @default.
• W3037821719 doi "https://doi.org/10.1159/000508535" @default.
• W3037821719 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7592942" @default.
• W3037821719 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32585675" @default.
• W3037821719 hasPublicationYear "2020" @default.
• W3037821719 type Work @default.
• W3037821719 sameAs 3037821719 @default.
• W3037821719 citedByCount "2" @default.
• W3037821719 countsByYear W30378217192021 @default.
• W3037821719 countsByYear W30378217192022 @default.
• W3037821719 crossrefType "journal-article" @default.
• W3037821719 hasAuthorship W3037821719A5009498218 @default.
• W3037821719 hasAuthorship W3037821719A5025132856 @default.
• W3037821719 hasAuthorship W3037821719A5027070167 @default.
• W3037821719 hasAuthorship W3037821719A5027365982 @default.
• W3037821719 hasAuthorship W3037821719A5030324982 @default.
• W3037821719 hasAuthorship W3037821719A5037601258 @default.
• W3037821719 hasAuthorship W3037821719A5039981023 @default.
• W3037821719 hasAuthorship W3037821719A5043422428 @default.
• W3037821719 hasAuthorship W3037821719A5045780806 @default.
• W3037821719 hasAuthorship W3037821719A5064831753 @default.
• W3037821719 hasAuthorship W3037821719A5065535191 @default.
• W3037821719 hasAuthorship W3037821719A5070984330 @default.
• W3037821719 hasAuthorship W3037821719A5071756329 @default.
• W3037821719 hasAuthorship W3037821719A5073438163 @default.
• W3037821719 hasAuthorship W3037821719A5083323267 @default.
• W3037821719 hasAuthorship W3037821719A5088330922 @default.
• W3037821719 hasAuthorship W3037821719A5091333394 @default.
• W3037821719 hasBestOaLocation W30378217191 @default.
• W3037821719 hasConcept C141105273 @default.
• W3037821719 hasConcept C159654299 @default.
• W3037821719 hasConcept C203014093 @default.
• W3037821719 hasConcept C2776946954 @default.

• next